Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.11, read 2026-10-24
Ethical does not pass the values gate
Price58.50 USD
Fair value30.93
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation52.20+12.1% to today ✓Markup gives way to Accumulation first Accumulation read since August
2026-09-14Read Markup50.46+15.9% to today ✓Accumulation gives way to Markup after a 24% rise in 4 weeks
2026-08-14Read Accumulation40.80+43.4% to today ✓Markup gives way to Accumulation with results news in the headlines
2026-07-02Read Markup42.12+38.9% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
BBB Foods Inc. holds its Accumulation at $58.50. Consolidating, no directional conviction, held for 35 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 35 days
Price at the screen
$58.50
Valuation
N/A trailing · 591.28 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.02
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
45.79%
Below 33%
Interest-bearing debt is 45.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
8.88%
Below 33%
Cash held in interest-bearing accounts and securities is 8.9% of assets, under the one-third limit.
Pass
Receivables
4.95%
Below 49%
Money owed to the company is 4.9% of assets, under the 49% limit.
Pass
Revenue purity
0.21%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
BBB Foods's business is in a permissible area, but its interest-bearing debt is about 46% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TBBB's ethical verdict changes
Today TBBB does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 47.1% above the base estimate.
Third-party analyst targets: 13 covering, consensus Buy. The average target sits +2% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Mexico discount shelves still running deep losses
Picture a shopper in Guadalajara grabbing cheap groceries off the shelf while the store behind them loses money on every basket. BBB Foods is racing to open more outlets and lift revenue 33 percent, yet it posts a 4 percent negative profit margin and an eye watering negative 78 percent return on equity. The forward multiple sits at negative 337 times because the business is not earning a penny.
We pass. A slim 10 percent gap to our fair value of 44.93 does not offset the fact that growth is being bought with heavy losses and no visible moat. Analysts may cluster around a 45 dollar target and the ethical screen clears, but the numbers show a company still far from consistent cash generation.
The real danger sits in execution risk inside a competitive Mexican market where currency moves and rising costs can widen losses fast. Defensive labels do not protect a firm whose returns remain this poor. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Mexico and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TBBB trades on the NYSE (the company is based in Mexico). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Accumulation$57.37+1.8%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (12 analysts) rates it buy, with a mean price target of $43. Since the last review it dropped out of the Titan Ethical 500; its composite score eased.
2026-10-18Accumulation$56.36+8.0%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (12 analysts) rates it buy, with a mean price target of $43.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (12 analysts) rates it buy, with a mean price target of $43.
2026-09-14Markup · changed$50.46+23.7%Entry 5
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 23.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (12 analysts) rates it buy, with a mean price target of $43.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (12 analysts) rates it buy, with a mean price target of $43.
2026-07-18Markup$42.12+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (12 analysts) rates it buy, with a mean price target of $43.
2026-07-03Markup$42.12+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$42.12Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
